Assessment of ophthalmic steroid class adverse event reports for loteprednol etabonate

Cavet Megan E.; Sanfilippo Christine M.; DeCory Heleen H.

首页> 外文期刊>Investigative ophthalmology & visual science >Assessment of ophthalmic steroid class adverse event reports for loteprednol etabonate

【24h】

Assessment of ophthalmic steroid class adverse event reports for loteprednol etabonate

机译：评估词素类药物类逆血事件报告的词素eTabonate

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Investigative ophthalmology & visual science》 |2017年第8期|共3页
作者
Cavet Megan E.; Sanfilippo Christine M.; DeCory Heleen H.;
展开▼
作者单位

Bausch Lomb Med Affairs Rochester NY USA;

Bausch Lomb Med Affairs Rochester NY USA;

Bausch Lomb Med Affairs Rochester NY USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词
入库时间 2022-08-19 22:32:18

相似文献

外文文献
中文文献
专利

1. Assessment of ophthalmic steroid class adverse event reports for loteprednol etabonate [J] . Cavet Megan E., Sanfilippo Christine M., DeCory Heleen H. Investigative ophthalmology & visual science . 2017,第8期

机译：评估词素类药物类逆血事件报告的词素eTabonate
2. Steroid-induced ocular hypertension with loteprednol etabonate 0.2percent--A case report [J] . Edeline Lu, Lane T. Fujimoto, Paul A. Vejabul, Optometry: Journal of the American Optometric Association . 2011,第7期

机译：依托泊洛替诺酯0.2％类固醇性高眼压一例
3. The Japanese version of the National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE): psychometric validation and discordance between clinician and patient assessments of adverse events [J] . Takashi Kawaguchi, Kanako Azuma, Motohiko Sano, Journal of Patient-Reported Outcomes . 2017,第1期

机译：国立癌症研究所患者报告的不良事件通用术语标准（PRO-CTCAE）的日语版：心理计量学验证以及临床医生与患者对不良事件的评估之间的不一致
4. Identifying Adverse Drug Reactions of Hypolipidemic Drugs from Chinese Adverse Event Reports [C] . Yu Zhang, Xuwen Wang, Liu Shen, 2018 IEEE International Conference on Healthcare Informatics Workshops . 2018

机译：从中国不良事件报告中识别降血脂药物的不良药物反应
5. Study on impacts of promotion of generic drug utilization on spontaneous adverse event reports and drug safety assessment at the post-market stage [D] . TAKAMI, Akina 2019

机译：上市后阶段推广仿制药利用对自发不良事件报告和药物安全评估的影响
6. The Japanese version of the National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE): psychometric validation and discordance between clinician and patient assessments of adverse events [O] . Takashi Kawaguchi, Kanako Azuma, Motohiko Sano, 2018

机译：国立癌症研究所患者报告的不良事件通用术语标准（PRO-CTCAE）的日语版：心理计量学验证以及临床医生与患者对不良事件的评估之间的不一致
7. Assessment of reported in-patient adverse events: retrospective study of reported adverse events at the Free State Psychiatry Complex from 2008-2010 [O] . Qhali Jacoline Martha 2015

机译：评估所报告的住院不良事件：回顾2008-2010年在自由州精神病学综合大楼所报告的不良事件
8. Does Uniformity of Topical Corticosteroid Ophthalmic Medications: Flourometholone Acetate 0.1 Suspension and Loteprednol Etabonate 0.5 gel. [R] . Bennion, J. 2017

机译：外用皮质类固醇眼科药物的均匀性：醋酸氟喹诺酮0.1悬浮液和依碳酸氯替泼诺0.5凝胶。

Assessment of ophthalmic steroid class adverse event reports for loteprednol etabonate

著录项

相似文献

相关主题

期刊订阅